Resveratrol

In 36 adult patients with type 2 diabetes, a single dose of 75 mg of resveratrol administered at weekly intervals showed significant improvements in neurovascular coupling capacity and cognitive performance.

A study of older overweight adults taking resveratrol (200 mg) and quercetin (320 mg) daily for 26 weeks led to significant improvements in memory performance.

In 17 volunteers with type 2 diabetes treated with 150 mg/day of resveratrol for 30 days, intrahepatic lipid content and systolic blood pressure decreased significantly. In overweight and obese men given resveratrol for two weeks (1 g first week, 2 g second week), reductions in intestinal and hepatic lipoprotein particle production were observed.

In 40 healthy volunteers who consumed resveratrol at doses of 0.5, 1.0, 2.5, or 5.0 g daily for 29 days, resveratrol decreased IGF-I and IGFBP-3 levels, with the highest reduction observed at 2.5 g dose, suggesting potential cancer risk reduction.

In 17 volunteers with type 2 diabetes treated with 150 mg/day of resveratrol for 30 days, intrahepatic lipid content and systolic blood pressure decreased significantly. In overweight and obese men given resveratrol for two weeks (1 g first week, 2 g second week), reductions in intestinal and hepatic lipoprotein particle production were observed.

In 40 healthy volunteers who consumed resveratrol at doses of 0.5, 1.0, 2.5, or 5.0 g daily for 29 days, resveratrol decreased IGF-I and IGFBP-3 levels, with the highest reduction observed at 2.5 g dose, suggesting potential cancer risk reduction.

A study of older overweight adults taking resveratrol (200 mg) and quercetin (320 mg) daily for 26 weeks led to significant improvements in memory performance.

In 17 volunteers with type 2 diabetes treated with 150 mg/day of resveratrol for 30 days, intrahepatic lipid content and systolic blood pressure decreased significantly. In overweight and obese men given resveratrol for two weeks (1 g first week, 2 g second week), reductions in intestinal and hepatic lipoprotein particle production were observed.

In nine healthy men and women who ingested 1 g/day resveratrol capsules for 28 days, resveratrol induced an increase in circulating T cells, reduced plasma levels of proinflammatory cytokines TNF-α and monocyte chemoattractant protein 1, and significantly increased plasma antioxidant capacity.

In nine healthy men and women who ingested 1 g/day resveratrol capsules for 28 days, resveratrol induced an increase in circulating T cells, reduced plasma levels of proinflammatory cytokines TNF-α and monocyte chemoattractant protein 1, and significantly increased plasma antioxidant capacity.

In nine healthy men and women who ingested 1 g/day resveratrol capsules for 28 days, resveratrol induced an increase in circulating T cells, reduced plasma levels of proinflammatory cytokines TNF-α and monocyte chemoattractant protein 1, and significantly increased plasma antioxidant capacity.